TOMMASINI, Silvana
 Distribuzione geografica
Continente #
EU - Europa 7.677
NA - Nord America 6.446
AS - Asia 3.963
SA - Sud America 1.244
AF - Africa 124
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.469
Nazione #
US - Stati Uniti d'America 6.355
RU - Federazione Russa 3.736
SG - Singapore 1.669
CN - Cina 1.134
BR - Brasile 1.093
IE - Irlanda 1.008
SE - Svezia 851
UA - Ucraina 498
HK - Hong Kong 446
DE - Germania 412
VN - Vietnam 268
GB - Regno Unito 248
FI - Finlandia 233
IT - Italia 223
FR - Francia 213
IN - India 130
PL - Polonia 73
AT - Austria 60
AR - Argentina 51
CA - Canada 42
TR - Turchia 40
BD - Bangladesh 39
MX - Messico 35
IQ - Iraq 34
ZA - Sudafrica 31
EC - Ecuador 27
MA - Marocco 26
CI - Costa d'Avorio 24
ID - Indonesia 23
JP - Giappone 22
ES - Italia 21
PK - Pakistan 20
UZ - Uzbekistan 20
VE - Venezuela 20
NL - Olanda 19
BE - Belgio 18
CZ - Repubblica Ceca 17
IR - Iran 16
AZ - Azerbaigian 13
TN - Tunisia 13
CL - Cile 12
CO - Colombia 12
UY - Uruguay 10
IL - Israele 9
KE - Kenya 9
NP - Nepal 9
AU - Australia 8
MY - Malesia 8
PE - Perù 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
EG - Egitto 6
ET - Etiopia 6
OM - Oman 6
PH - Filippine 6
DZ - Algeria 5
LT - Lituania 5
LV - Lettonia 5
PS - Palestinian Territory 5
RS - Serbia 5
EU - Europa 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
KR - Corea 4
KZ - Kazakistan 4
NO - Norvegia 4
RO - Romania 4
SA - Arabia Saudita 4
AL - Albania 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
GE - Georgia 2
GR - Grecia 2
MD - Moldavia 2
MK - Macedonia 2
MN - Mongolia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
Totale 19.458
Città #
Moscow 1.112
Dublin 1.008
Jacksonville 947
Singapore 870
Ashburn 776
Chandler 659
Nyköping 502
Dallas 471
Hong Kong 445
Beijing 356
San Jose 306
Dearborn 203
The Dalles 174
Princeton 166
Cambridge 161
Los Angeles 161
Medford 152
Lauterbourg 144
Dong Ket 140
Des Moines 125
Boardman 109
Messina 92
Ann Arbor 83
Buffalo 80
São Paulo 77
New York 72
Lancaster 69
Tianjin 65
Warsaw 65
Jinan 58
Vienna 57
Munich 54
Guangzhou 52
Ho Chi Minh City 51
Woodbridge 51
Wilmington 49
Turku 42
San Mateo 41
Shenyang 40
Pune 38
Council Bluffs 37
Redondo Beach 35
Rio de Janeiro 34
Orem 31
Helsinki 29
Belo Horizonte 28
Chennai 28
Hangzhou 28
Brasília 26
Nanjing 26
Brooklyn 25
Houston 25
Abidjan 24
Augusta 24
Frankfurt am Main 24
Atlanta 22
Tokyo 21
Bremen 20
Campinas 20
Hanoi 20
Montreal 20
Nanchang 20
Haikou 19
Shanghai 19
Tashkent 19
Brussels 18
Johannesburg 18
Leawood 18
London 16
Santa Clara 16
Shenzhen 16
Boston 15
Chicago 15
Denver 15
Mumbai 15
Poplar 15
Zhengzhou 15
Curitiba 14
Hebei 14
Phoenix 14
Porto Alegre 14
Salvador 14
Seattle 14
Ankara 13
Brno 13
San Francisco 13
Stockholm 13
Baku 12
Manchester 12
Ningbo 12
Nuremberg 12
Amsterdam 11
Ardabil 11
Baghdad 10
Casablanca 10
Manaus 10
Mexico City 10
Bexley 9
Edinburgh 9
Guarulhos 9
Totale 11.212
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 262
Analysis of the thermal fluctuations in inclusion complexes of genistein with β-cyclodextrin derivatives 252
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 224
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 202
Anticonvulsant agent: enhancement of physicochemical properties 198
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 191
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 191
CHITOSAN/SULFOBUTHYL ETHER BETA-CYCLODEXTRIN NANOPARTICLES FOR IDEBENONE DELIVERY 190
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 181
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 179
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 176
A characterization study of resveratrol/sulfobutylether-b-cyclodextrin inclusion complex andin vitro anticancer activity 176
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 171
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 171
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 171
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 168
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 166
Acyclovir-b-cyclodextrin prodrugs: an in vitro evaluation for oral administration”. 166
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 165
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 165
Analytical profile and release of lonidamine from pharmaceutical formulation 165
DETERMINATION OF FLAVONOIDS BY TURBIDIMETRIC MEASUREMETS 162
Chitosan nanospheres containing cyclodextrins for idebenone delivery 160
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 158
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 157
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 157
B-Cyclodextrin conjugates for sustained release of drugs 156
PLGA/AMPHIPHILIC CYCLODEXTRIN NANOPARTICLES LOADING METHYLENE BLUE FOR NOSE-TO-BRAIN TARGETING IN ALZHEIMER'S DISEASE 156
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 155
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 154
Amphiphilic beta-cyclodextrin nanoparticles encapsulating a carotenoid for drug delivery 154
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 153
Nanotherapeutics for anti-inflammatory delivery 153
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES. 152
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 151
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 150
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 150
Celecoxib-loaded PLGA/cyclodextrin microspheres: Characterization and evaluation of anti-inflammatory activity on human chondrocyte cultures 150
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 149
Gemcitabine-Loaded Chitosan Microspheres For Local Delivery In Lung, 147
ANTIINFLAMMATORY ACTIVITY OF PLANTS IN TRADITIONAL MEDICINE: CORDIA MYXA L., C. FRANCISCI TEN., C. SERRATIFOLIA H.B.K. 146
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 143
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 143
Preparation, characteristics and biological evaluation of micro and nanostructured carriers for controlled release 142
“Host-guest” interactions in Captisol®/Coumestrol inclusion complex: UV-vis, FTIR-ATR and Raman studies 142
CHIRAL RECOGNITION AND COMPLEXATION BEHAVIOUR OF BETA-CD vs. L- AND D,L-SERINE BY FTIR-ATR SPECTROSCOPY 141
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 140
SPETTRI DI RIFLESSIONE DI FLAVONOIDI DEDOTTI MEDIANTE TRASFORMATA DI KUBELKA-MUNK . 138
Biodegradable microparticles as carrier for moxifloxacine 136
null 135
BIODEGRADABLE MICROSPHERES FOR INTRAARTICULAR ADMINISTRATION OF CELECOXIB 135
BETA-CYCLODEXTRIN CONJUGATES FOR SUSTAINED RELEASE OF DRUGS 135
Determination of fludarabine in a pharmaceutical formulation by LC 134
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 133
GEMCITABINE-LOADED CHITOSAN MICROSPHERES FOR LOCAL DELIVERY IN LUNG 133
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 131
Phase solubility and FTIR-ATR studies of idebenone/sulfobutyl ether b-cyclodextrin inclusion complex 126
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 126
Structural and spectroscopic features of lutein/butanoyl-beta-cyclodextrin nanoassemblies 125
Temperature-dependent dynamical evolution in coum/sbe-β-cd inclusion complexes revealed by two-dimensional ftir correlation spectroscopy (2d-cos) 125
METHODS FOR PARTICLE SIZE DETERMINATION IN POWDERS OF PHARMACEUTICAL INTEREST. Nota II 124
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 122
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 120
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 119
Study of the inclusion complex of atenolol with beta- cyclodextrins 119
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 118
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 117
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 117
New formulation of cyclodextrin nanoassemblies as delivery system for idebenone 117
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 116
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 115
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 115
null 115
Chitosan/hyaluronan nanoparticles: a promising tool in cancer immunotherapy 113
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 112
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 112
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 112
PREPARATION AND CHARACTERIZATION OF GEMCITABINE-LOADED CHITOSAN MICROSPHERES 112
Gemcitabine anticancer activity enhancement by water soluble celecoxib/ sulfobutyl ether-β-cyclodextrin inclusion complex 112
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 111
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 108
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 106
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 105
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 105
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 105
Solid-state study of polymorphic drugs: carbamazepine 104
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 103
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 103
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 103
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 103
MOXIFLOXACIN-LOADED CHITOSAN MICROSPHERES FOR INTRAPULMONARY ADMINISTRATION 102
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 100
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 99
Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate 99
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
Interaction of a functionalized complex of the flavonoid hesperetin with the AhR pathway and CYP1A1 expression: involvement in its protective effects against benzo[a]pyrene-induced oxidative stress in human skin. 98
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 97
Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies 97
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 97
Totale 13.911
Categoria #
all - tutte 63.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 0 0 0 0 0 0 182
2021/20221.116 26 203 16 31 20 2 86 50 5 127 207 343
2022/20232.942 221 213 141 203 266 280 62 172 1.244 17 98 25
2023/2024547 76 105 52 66 53 116 12 21 0 15 2 29
2024/20253.041 48 51 59 192 113 67 40 694 756 187 283 551
2025/20268.427 426 487 579 631 729 2.007 1.145 984 997 319 123 0
Totale 19.597